Brandy Fureman

1 INTRODUCTION Epilepsy surgery remains the most effective treatment for focal drug-resistant epilepsy (DRE).1 When resective/ablative surgery is not feasible, invasive neuromodulation can palliate seizure burden and reduce morbidity and mortality.2 Despite its known benefits, access to epilepsy surgery is not equal in the United States, with Black or African American patients being ~50%–70% less likely to undergo epilepsy surgery than White or Hispanic patients.3, 4 Regarding...

Abstract Onset of many forms of epilepsy occurs after an initial epileptogenic insult or as a result of an identified genetic defect. Given that the precipitating insult is known, these epilepsies are, in principle, amenable to secondary prevention. However, development of preventive treatments is difficult because only a subset of individuals will develop epilepsy and we cannot currently predict which individuals are at the highest risk.

Publication HistoryPublished online: September 05, 2018Accepted: July 12, 2018; Received in revised form: June 18, 2018; Received: March 30, 2018;